What are the Major Stock Market Risks for 2024?
https://www.zacks.com/commentary/2216190/what-are-the-major-stock-market-risks-for-2024?cid=CS-ZC-FT-spoken_word-2216190
Jan 25, 2024 - After Davos is over, let's prognosticate from the cheap seats.
0
Big Earnings Afternoon: Microsoft, Alphabet, Starbucks & More
https://www.zacks.com/stock/news/2218328/big-earnings-afternoon-microsoft-alphabet-starbucks-more?cid=CS-ZC-FT-ahead_of_wall_street-2218328
Jan 30, 2024 - Microsoft, Google-parent Alphabet, Mondelez and Skyworks all topped earnings expectations.
0
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2218712/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2218712
Jan 31, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Novo Nordisk (NVO) Q4 2023 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/01/31/novo-nordisk-nvo-q4-2023-earnings-call-transcript/?source=iedfolrf0000001
Jan 31, 2024 - NVO earnings call for the period ending December 31, 2023.
0
Pharma Stock Roundup: PFE, MRK, NVO & SNY's Q4 Earnings, FDA Updates
https://www.zacks.com/stock/news/2220214/pharma-stock-roundup-pfe-mrk-nvo-sny-s-q4-earnings-fda-updates?cid=CS-ZC-FT-analyst_blog|stock_roundup-2220214
Feb 02, 2024 - Pfizer (PFE), Merck (MRK), Novartis (NVS), Novo Nordisk (NVO) and Sanofi (SNY) announce fourth-quarter and full-year 2023 results.
0
Novo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B
https://www.zacks.com/stock/news/2221276/novo-nordisk-nvo-to-acquire-3-catalent-sites-for-11b?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2221276
Feb 05, 2024 - Novo Nordisk (NVO) will acquire Catalent's three manufacturing sites from Novo Holdings to expand its manufacturing capacity.
0
Why Novo Nordisk (NVO) is a Top Stock for the Long-Term
https://www.zacks.com/stock/news/2224747/why-novo-nordisk-nvo-is-a-top-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_focus_list-2224747
Feb 12, 2024 - The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
0
Novo Nordisk's Magic Run Continues Even With Increasing Competition
https://www.fool.com/investing/2024/02/12/novo-nordisks-magic-run-continues-even-with/?source=iedfolrf0000001
Feb 12, 2024 - Novo Nordisk's Q4 earnings were rock solid as momentum in the diabetes and obesity markets continued to fuel growth.
0
Novo Nordisk Has More Than Ozempic. One of Its Other Treatments Grew 393% Last Year.
https://www.fool.com/investing/2024/02/18/novo-nordisk-has-more-than-ozempic-one-of-its/?source=iedfolrf0000001
Feb 18, 2024 - It may be best known for its diabetes treatment, Ozempic, but Novo Nordisk has a host of other blockbuster drugs, too.
0
New to Investing? This 1 Medical Stock Could Be the Perfect Starting Point
https://www.zacks.com/stock/news/2235993/new-to-investing-this-1-medical-stock-could-be-the-perfect-starting-point?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_focus_list-2235993
Mar 05, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
0
Page 1>